(19)
(11) EP 3 976 017 A1

(12)

(43) Date of publication:
06.04.2022 Bulletin 2022/14

(21) Application number: 20813466.8

(22) Date of filing: 01.06.2020
(51) International Patent Classification (IPC): 
A61K 31/167(2006.01)
A61K 45/06(2006.01)
A61K 31/423(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/423; A61K 31/661; A61K 31/662
(86) International application number:
PCT/US2020/035592
(87) International publication number:
WO 2020/243720 (03.12.2020 Gazette 2020/49)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 31.05.2019 US 201962855560 P

(71) Applicant: Plex Pharmaceuticals, Inc.
San Diego, California 92121 (US)

(72) Inventors:
  • PRASAD, Sridhar Govinda
    San Diego, California 92129 (US)
  • PETERMAN, Marshall Clarke
    Oceanside, California 92054 (US)
  • SINHA, Santosh
    Ladera Ranch, California 92694 (US)

(74) Representative: Patentanwälte Bressel und Partner mbB 
Potsdamer Platz 10
10785 Berlin
10785 Berlin (DE)

   


(54) PHARMACOLOGICAL AGENTS FOR TREATING PROTEIN AGGREGATION DISEASES OF THE EYE